Advantis Medical Imaging has secured the European CE-Mark for the use of its cloud-based neuroimaging software called Brainance MD as part of the clinical workflow in advanced processing of brain magnetic resonance (MR) images.
The software combines diffusion tensor imaging, DSC perfusion and functional MRI in a single user platform to display, process and analyse the MR images.
Accessible from a web-browser, Brainance MD supports remote and collaborative analysis.
It comes with reporting and visualisation capabilities to help healthcare professionals in optimising their daily clinical practice and enables working in a completely zero-footprint platform.
Advantis Medical Imaging CEO and co-founder Zoi Giavri said: “This is a significant milestone for our company and the fact that Brainance MD can now be integrated in the clinical processing workflow fulfils one of Advantis principal goals: to make state-of-the-art processing methodologies available for every doctor, anywhere, anytime.”
Brainance MD is in line with the Digital Imaging and Communications in Medicine (DICOM) standard and compatible with picture archiving and communication systems (PACS).
The technology is being offered as a Software As A Service (SaaS) to provide high quality and increased scalability for both large and small organisations.
Advantis Medical Imaging COO and co-founder Paris Ziogkas said: “This CE-Mark approval confirms our capacity for innovation and justifies the entire team’s devotion and effort on striving for increased quality and performance while bringing added value to the daily clinical practice.”
Founded in 2016, Advantis Medical focuses on using deep learning methodologies, both in its existing and new software solutions, to provide advanced medical image processing for clinical use.